Will UK borrowing highs lead to new austerity measures?

UK government borrowing between April and June has jumped to £127.9bn, the highest amount since records began in 1993. In order to combat the effects of the Coronavirus pandemic, borrowing in the first quarter of the 2020-21 financial year was more than double than the entire previous year. Last week, finance minister Rishi Sunak set out further spending plans of £30bn, to encourage employers to continue hiring workers after the furlough scheme is set to end in October. “The best approach to ensure our public finances are sustainable in the medium-term is to minimise the economic scarring caused by the pandemic. I am also clear that, over the medium-term, we must, and we will, put our public finances back on a sustainable footing,” he said. Due to the high levels of government borrowing, there is a possibility that Sunak could use the Autumn budget to launch new austerity measures of raise taxes to combat the unsustainable trajactory of UK public finances. Resistant to comment on future tax changes, Sunak did say last week: “Fundamentally we don’t tax our way into prosperity. We want people to share more of their own money. But we also have a lot of demands on public services, and they need to be funded.” The Centre for Macroeconomics (CfM) has carried out research with leading economists and found that there was a little concern of future deficit. Gerard Lyons, a senior fellow at the thinktank Policy Exchange, said new rounds of austerity would be a mistake. He said: “The idea should be to reduce the deficit over time through a pro-growth strategy. A rising budget deficit acts as a shock absorber during this crisis and we should be grateful for it.”

NextGen Nano: Next Generation of Nanotechnology

Sponsored by NextGen Nano NextGen Nano is a high-tech company with a focus on the empowerment of the individual. By decentralising power generation from governments and traditional grids, we are striving to have a deliberate positive environmental impact, whilst reducing reliance on pollutants and finite materials. NextGen Nano has developed benchmark IP that may hold the key to advancements in the decentralising of energy, in line with recent Government CO2 emission and climate policy goals. Download the investor presentation here Our breakthrough technology replaces existing solutions (fabricated with pollutant, finite materials) with earth-friendly biopolymers. This breakthrough enables NextGen Nano to develop solar cells that produce energy with unrivalled efficiency at a far lower cost than existing hardware. This technology allows robust, transparent cells to be applied to flexible surfaces, thus making it more usable and cost-effective than ever before, as well as practical for multiple potential real-world applications. The company is headed by DR Franky So. Dr Franky So holds 80 issued patents and has published more than 160 peer-reviewed articles. He is the editor-in-chief of the journal Materials Science and Engineering Reports and serves as an associate editor for IEEE Journal of Photovoltaics, IEEE Journal of Display Technology, SPIE Journal of Photonic Technology and Organic Electronics. Franky is the former head of the OLED research group at Motorola, where he was named a Distinguished Innovator and Master Innovator. He is a Lecturer of the IEEE Photonics Society, a Charter Fellow of the National Academy of Inventors, and a Fellow of IEEE, OSA and SPIE. In 2015, he joined the Department of Materials Science and Engineering at the North Carolina State University, where he is currently the Walter and Ida Freeman Distinguished Professor. Download the investor presentation here Article written and sponsored by NextGen Nano

Over a quarter of City’s finance teams not returning to the office this month

1
Despite the prime minister’s proposal of a “significant return to normality” by Christmas, it appears many businesses aren’t planning a rapid return to the old normal. Many are either streamlining their divisions, or in the case of finance teams, few provisions have been made for a return to the office in the near future. Boris Johnson stated on Friday that the onus would be on employers to bring their staff back to work safely from August 1, but despite this, it appears most City firms aren’t raring to get back to the old way of doing things. Of it’s 6,000 London staff, Goldman Sachs has only returned 800 to the office, while fewer than 2,000 of JP Morgan’s 12,000 workforce are back to normal.

According to research performed by accounting and consultancy firm, Theta Financial Reporting, over 26% of Brits surveyed say their company’s finance teams will not be returning to the office with other staff this month, and will now work at home for the majority of the time. It added that 24% of those surveyed said that their employer hadn’t explored any flexible working options to help staff return to work.

It continued, stating that 70% of City-based staff now feel uncomfortable commuting to work via public transport, with these people also saying that journeys to and from the office will become one of the most stressful parts of the day. Also, according to the company’s research, some 29% of business leaders said they had permanently streamlined their team in response to the COVID pandemic, with many finding certain roles to be unnecessary luxuries. The company are in favour of flexible working arrangements, and said that its research illustrated a lack of desire to return to pre-pandemic working conditions. Speaking on the report, Theta Financial Reporting Founder and Managing Director, Chris Biggs, commented:

“This research demonstrates the clear desire for people both in the Capital and finance teams not to return to their pre-COVID working environments, regardless of the calls from the Prime Minister to return to normality before Christmas.”

“Many businesses have adapted to working away from the office and with so many people caring for vulnerable relatives, friends and children, it seems people do not want to return in July or August, despite the easing of lockdown restrictions. This will have a significant impact on how our workplaces will look beyond lockdown.”

“From the commute to boosted productivity when working from home, there are numerous benefits to flexible working that this period has uncovered for millions of employers and employees alike. Business leaders would do well to realise this and adapt now to pivot their business, remove unnecessary overheads and plan for a post-COVID future.”

The future of potential work-from-home or home-office hybrid arrangements has already been an issue widely discussed during lockdown, and it will be interesting to see whether some of the suggestions made will come into force or simply fade away as a passing fad. For now, though, it is important that whatever working arrangements are in place encourage both the greatest extent of staff safety, and productivity.

Instem shares rally on successful fundraise and revenue spike

Provider of IT services to the global life sciences market, Instem (AIM:INS) saw its shares rally on Monday as it announced a successful half-year of trading. The company stated that it, “[…] continued to perform well across all areas of the business despite the wider backdrop and macro impact of COVID-19.” It added that trading was in line with its board’s expectations, with revenues bouncing by around 20%, and like-for-like revenues – excluding acquisitions – rising 12% year-on-year for the first half. Instem said that its cash generation remained strong, with its cash position at period-end standing at £9.1 million, up from £6.0 million on-year.

It continued, noting that it raised £15.75 million in its ‘oversubscribed’ fundraise, which was approved by shareholders on the July 16 and completed post-period-end. With the proceeds of the fundraiser, the company said it had identified ‘substantial’ targets, and would focus on adding bolt-on acquisitions.

Instem stated that it had suffered a setback with its inability to undertake client site based professional services and secure new software licences in the academic segment. However, the period also yielded positive news, with recent acquisition Leadscope trading stronger than anticipated.

Instem response

Commenting on the results, CEO Phil Reason, stated: “Trading during the Period highlighted the resilience of our operations and the dedication of the entire Instem team as the Company continued to grow despite the COVID-19 backdrop. We have been delighted to directly contribute to our clients’ COVID-19 vaccine and therapy-related R&D activities and remain committed to prioritising these efforts over the second half. Following completion of the fundraise, we also aim to drive revenues and margins as we look to further consolidate the market.”

Investor insights

Following the update, Instem shares rallied by 1.32% or 6.00p, to 460.00p per share 20/07/20 12:34 BST. This is far ahead of its year-to-date nadir of 375.00p on March 25, but below its 530.00p high on June 3. The company’s p/e ratio currently stand at 23.52.

Sour start for FTSE 100 amid brewing UK-China tensions

0
The FTSE 100 index (INDEXFTSE:UKX) opened on a sour note on Monday morning, sinking to a low of 6225.11 points at BST 08:25 on the back of slow progress at the EU rescue deal summit and ongoing tensions between the UK and China over Hong Kong and allegations of abuse against Uighur Muslims.

EU nations struggle to reach a rescue deal

European markets have so far been toiling with the news of a potential €750 billion bail-out from the European Union to help offset the coronavirus-induced economic depression. City A.M. reported earlier today that the so-called ‘frugal four’ – the Netherlands, Austria, Denmark and Sweden – had been withholding confirmation on the deal, citing concerns that the proposed grants were too generous to the debt-racked Southern countries. An agreement was reportedly reached in the early hours of Monday morning following three days of tense talks, on the condition that €390 billion of the emergency fund be distributed as grants – a notable decrease from the EU’s initial proposal of €500 billion. Still, Dutch Prime Minister Mark Rutte dampened hopes of a sealed deal just yet, stating: “We are not there yet, things can still fall apart. But it looks a bit more hopeful than at the times were I thought last night that it was over”. Talks are set to continue on Monday afternoon, with Austrian Chancellor Sebastian Kurz offering a slightly more optimistic comment: “Tough negotiations have just come to an end and we can be very satisfied with today’s result. We will continue in the afternoon”. Even with a hefty EU bail-out set to give European economies a much-needed boost, the FTSE appears to have latched onto the initial reluctance of the ‘frugal four’, although it is not the only concern for London’s blue chips at the start of the week.

Tensions brew between the UK and China

The ongoing spat between the UK and China over Hong Kong has continued to escalate over the past few days, with the BBC reporting that Foreign Secretary Dominic Raab is expected to suspend the UK’s extradition treaty with Hong Kong at an announcement in Parliament later today, severing a decades-long arrangement with Beijing. Footage released to the public over the weekend – allegedly showing evidence of the reported mass abuse and incarceration of Uighur Muslims – was strenuously denied by China’s ambassador to the UK, Liu Xiaoming, in an interview with the BBC yesterday. The images, which appear to show Uighurs being forcibly blindfolded and led onto trains, have since been verified by Australian intelligence. While Xiaoming dismissed talks of concentration camps as simply “fake”, and Foreign Ministry spokesman Wang Wenbin challenged allegations of forced sterilisation of Uighur women as “nothing but lies”, tensions between the UK and China look set to simmer for some time yet, and have kept the FTSE decidedly in the red throughout Monday morning as the index struggles to buoy itself. Chinese markets nonetheless appear to be unfazed by the allegations, with the SSE Composite Index (SHA:000001) up by 3.11% to 3,314.15 points at GMT+8 15:00.

Some good news from big pharma

Despite all the concerns over the EU and China, reports that UK-based drug developers Synairgen (SYN:LON) have discovered a potentially life-saving treatment for coronavirus patients has injected a good dose of optimism into market sentiment, helping to lift the FTSE up to 6,254.73 by midday – still down by 35.57 points though. The company’s shares have soared on the back of the news, up by 497.26% to 218.00p at BST 12:21.

Synairgen share price jumps over 380% on positive COVID-19 treatment results

Synairgen shares (LON:SNG) rocketed over 380% on Monday morning after the AIM-listed company released positive results from a trail of a COVID-19 treatment. The trial involved Synairgen’s SNG001 which was directly delivered to the lungs via nebulisation to help promote the bodies own immune response to the COVID-19 virus. Synairgen found that those given SNG001 during the trail were 79% more likely to recover than those that were given a placebo. In particularly encouraging findings, of those given a placebo drug, three people sadly died, but of the group given Synairgen’s SNG001, there were no deaths recorded.   “We are all delighted with the trial results announced today, which showed that SNG001 greatly reduced the number of hospitalised COVID-19 patients who progressed from ‘requiring oxygen’ to ‘requiring ventilation’,” said Richard Marsden, CEO of Synairgen. The Synairgen CEO also pointed to positive results relating to the recovery of patients to a level of fitness similar to before they caught COVID-19. “It also showed that patients who received SNG001 were at least twice as likely to recover to the point where their everyday activities were not compromised through having been infected by SARS-CoV-2.” “In addition, SNG001 has significantly reduced breathlessness, one of the main symptoms of severe COVID-19. This assessment of SNG001 in COVID-19 patients could signal a major breakthrough in the treatment of hospitalised COVID-19 patients. Our efforts are now focused on working with the regulators and other key groups to progress this potential COVID-19 treatment as rapidly as possible.”

Synairgen share price

The Synairgen share price rose a bumper 380% to 177.5p in mid morning trade on Monday, meaning the shares were up over 2,900% in 2020 alone. Synairgen shares traded as low as 5.8p in December 2019. Whilst current Synairgen investors will be cheering today’s jump, the move will be particularly painful for prior investors in Neil Woodford’s equity fund. Woodford had held the stock in the Woodford Equity Income Fund, but liquidators sold the Synairgen holding at a significant discount to the market price last month.  

M&S to cut hundreds of jobs in response to pandemic

0
Marks & Spencer (M&S) will reportedly announce hundreds of job cuts this week. According to a Sky News report, the retailer will be revealing a redundancy plan that may affect thousands of employees. During the lockdown, M&S closed between 100 – 120 stores and furloughed 27,000 of its 78,000 employees. Many of these employees have now returned back to work, however, may risk upcoming redundancy. An M&S spokeswoman has said in response to the Sky News report: “We don’t comment on speculation and, if and when we have an announcement to make, our colleagues will be the first to know.” Following results two months ago, the company formed a plan called ‘Never the same again’. As well as job cuts that are expected to be announced this week, earlier the chief executive, Steve Rowe, said in May that the pandemic will result in permanent changes to shopping habits. Rowe said: “Whilst some customer habits will return to normal others have changed forever, the trend towards digital has been accelerated, and changes to the shape of the high street brought forward. Most importantly working habits have been transformed and we have discovered we can work in a faster, leaner, more effective way.” The group’s boss has agreed to a pay freeze over the course of the pandemic and said he will not accept his an annual bonus for two consecutive years. The retailer is the latest of a series of companies that have suggested large-scale job cuts in response to the pandemic. John Lewis, Debenhams, and Boots have announced redundancy plans. Boots said that it will cut 4,000 jobs and axe 48 stores following a 72% fall in sales in Boots opticians and a 48% drop in Boots pharmacy stores. Shares in M&S (LON: MKS) are trading down 2% on Monday morning (0900GMT)      

Biden favourite to win presidency: how investors should ride the ‘blue wave’

Between Donald Trump’s handling of the COVID pandemic, protests and ongoing investigations into his potential involvements in several scandals, the US president has certainly seen his stock fall in the last couple of months. While most of his cards will rest upon his ability to inspire a quick economic bounce-back from the virus, most polling outlets and pundits currently peg Joe Biden as the favourite to become the next US president in November. Should the blue wave prediction come to fruition, what should investors do about it?

How likely is a Biden presidency?

In a recent report, financial services and research company StoneX sought to answer questions about the likelihood of a Democrat victory, and what investors should do if such as scenario were to play out. Data science company Ravenpack have given Biden a generous lead in their predictions, beating Trump with an estimated 308 votes to 230, and a 90% chance of victory. Meanwhile, and likely more in line with consensus predictions, StoneX said betting odds were consistent with a 60/40 likelihood of the Democrat candidate winning the presidency, which follows his 10 point lead in the RealClearPolitics poll average. In the House of Representatives, the company report that there is an 85% that the Democrats will retain their majority; they added that these odds have never fallen below 50% and that they ‘would not consider’ the hypothesis that the Republicans take control of the House in November. Further, and more interestingly, perhaps, StoneX report that current odds imply a 63% chance that the Democrats will win a majority in the senate. Should these three predictions come to pass, this would invoke what has been dubbed the ‘blue wave’, and ultimately sweeping control of all forces of law-making and review outside of the Supreme Court. However, we ought to note the very real possibility of a Republican comeback in polling for the senate, with the party’s odds of winning a majority standing at over 70% consistently until February. Further, and crucially – in my view – we can never underestimate the Trump brand of politics. After being largely written off by bookies in 2016, he secured a narrow win. Also, regardless of what we might make of him as an individual, his US-first approach to international trade, diplomacy and military intervention has really struck a chord with lots of disgruntled Americans, and I don’t think this sentiment has dissipated over the last four years. Two other factors, while more minor, may also help his cause: while his response to the BLM protests may have polarised opinion, some fence-sitters may actually prefer his hard-line approach. Also, though likely a small number, there is a chance that out of either defiance of his less progressive tone, or protest against Sanders’s defeat, some of the more extreme left-wing voters may opt not to vote for Biden.

What do Democrat victories do to shares?

The real possibility of a changing tide in polling aside, for the sake of StoneX’s report, we’ll imagine that the Biden blue wave comes to fruition, and according to the current analysis, this is the most likely combination of outcomes. So what does this mean? Well, it is important to note that ‘blue waves’ tend to display two key characteristics for investors. First, they tend to be good for shareholders (largely due to the second characteristic). Second, they tend to follow major economic calamities, such as the Great Depression or the 2008 Financial Crash, and therefore tend to oversee the recovery period. As stated in the StoneX report: “Looking at the average of the past six “blue waves”, stocks have tended to fall by 10 percentage points in the five months preceding the swearing in of a new Democratic President. This would suggest that the market should peak in August and experience a double-digit correction in the fall, which is conveniently consistent with the normal seasonal pattern of U.S. equity indices.” “Biden’s tax plans would also support the forecast of a double-digit decline in stocks as investors start pricing in the impact of tax increases on corporate earnings. The Biden campaign has proposed about $3.4 trillion in tax increases to fund infrastructure, climate investments, education, and healthcare.” Now of course there is a notable difference between tax rates and actual tax paid. For instance, regardless of Donald Trump’s change of corporation tax from 16% to 10%, the average tax actually paid by S&P 500 companies in the US was consistently between 3-4%. So the initial pricing in of a Democrat presidency would be reflected in shares, even if the actual effects aren’t felt by company earnings.

How to splash the green in a sea of blue

With these facts in mind, here are a few of the trends to anticipate in a Biden presidency. First, there’ll be greater scrutiny on how companies spend their money. While the presidential hopeful called on companies in a Twitter post not to commence buy-back plans within the next year, actively placing restrictions on buy-backs across the board will likely not be a priority for a new Democrat administration. What might have an impact, though, is greater scrutiny of companies receiving Fed financial aid and emergency loans, which may include restrictions on buy-backs. This may not adversely affect big hitters such as tech giants, however sectors such as healthcare, financials and industrials may feel the squeeze of some constraints. These sectors have all relied on government hand-outs to survive the COVID pandemic, and between them having made up 44% of all buy-backs within the last two years, StoneX predicts “a suspension of repurchases would lead to a significant reduction in the demand for stocks”. Secondly, and much like Trump, Biden’s seeming disregard for the deficit will likely contribute to inflationary pressure. While the Fed’s gung ho attitude to spending in April might lead to inflationary pressures in the long run, the short-term behaviour change of individuals was to save rather than spend money. Should Biden implement his $15 per hour Federal Minimum Wage policy and enhanced unemployment benefits, as well as offering an exact timeline for these policies to come about, StoneX state he could release a lot of ‘pent-up demand’. This, in combination with his currently uncosted $700bn ‘Buy American’ campaign, would likely put strong upward pressure on inflation. Thirdly, we could see a replay of the 2008-2010 trends, with gold and commodities soaring and emerging markets outperforming. With Biden being open about his ambitions for less isolationist policy (trying to join the TTP Treaty and rolling back tariffs on China) alongside income growth, widening deficits, tax increases and high inflation creating a weaker dollar, international and emerging economies would be less burdened by their USD-denominated liabilities, and would have a huge market once again open for trading. Fourth, out-of-network private hospital services, big pharma and insurers are likely to take a hit. Between lowering the eligibility age for Medicare – from 65 to 60 – and banning insidious “surprise billing” practices (when someone checks into an in-network and is then transferred to out-of-network services and charged extortionately), hospital providers will incur higher costs and take in less money. Also, more cost controls and transparent pricing measures – including limits of price increases, banning ‘abusive pricing’ on generic drugs and repealing the law which bans Medicare from negotiating drug prices with suppliers – would hit Big Pharma shares. Finally, introducing a subsidised public care and insurance service, alongside restrictions on insurers’ ability to increase premiums, will have negative implications for US health and care insurer stocks. As stated in the StoneX report: “The main investment implications are already playing out: international healthcare stocks, which are less exposed to U.S. regulatory risk, have outperformed as the probability of a November blue-wave has risen.” Fifth, and finally, clean energy and home-building stocks can expect to have their day in the sun. Trying to keep a firm grip on the next generation of progressive voters, Biden has promised to invest $640 billion over 10 years so every American has access to housing that is affordable, stable, safe and healthy, accessible, energy efficient and resilient, and located near good schools and with a reasonable commute to their jobs. Regardless of the actuality of these promises, we can expect, at least to some extent, that renewables and construction stocks will see a resurgence under a Democrat clean sweep. In conclusion, if you believe the Biden blue wave hype, look to inflation-sensitive assets, emerging markets, house-builders and clean energy as money-makers, and short health and care insurers and big pharma!
 

Pandemic sees up to 64% of businesses lose revenue with arts worst hit

2
On Thursday the ONS posted some of its damage assessment statistics for the Coronavirus pandemic, which entailed a relatively understated job loss estimate of under 700,000, as well as detailing the losses of turnover incurred by businesses that continued trading.

Where were businesses hardest hit?

Country-by-country, Scottish and Welsh businesses fared worst. Around 62% of Scottish firms reported a downturn in revenue outside of normal ranges, which was the highest country-wide loss of turnover. This was likely led by the Scottish government’s more stringent approach to lockdown measures, which has exacerbated the adverse effects on businesses, but has also seen the country’s death rates fall more quickly than their other UK counterparts. Meanwhile, Welsh businesses were noted as the most ‘at-risk’, with the lowest levels of resilience in terms of preparedness and cash reserves. Some 44% of enterprises were noted as having less than six months-worth of cash reserves, with this number falling to 41% in England, and 37% and 35% respectively in Scotland and Northern Ireland. Elsewhere, business turnover fell by 58% in England and Wales and 49% in Northern Ireland, with 28% of still-trading businesses in Northern Ireland saying that their turnover had been unaffected. Overall, then, Northern Ireland were the best-organised member of the UK to cope with the impact of the virus, while Welsh businesses, in sum, were the most vulnerable. By specific region, rather than country, Yorkshire and Humber, the West Midlands, North West and South West of England, all reported that over 60% of their still-trading businesses had lost turnover. The North East of England, though, suffered worst, with 64% of businesses reporting a drop in revenues.

Which sectors bore the brunt of the pandemic?

Unsurprisingly, the ONS reported that the arts, entertainment and recreation were worst-off due to the pandemic, with some 61% of all businesses in the sector still closed and just under half of the ventures saying that they weren’t planning to reopen in the next two weeks. Hotels, restaurants and bars were also, unsurprisingly, among the worst hit. While 26% currently of closed outlets said they would be looking to reopen soon, 22% of the currently-closed group said they had no plans to recommence trading in the next two weeks. With a small glimmer of positivity, the ONS stated that: “There were three industries where 99% or more of businesses reported continuing to trade (including trading for more than the last two weeks or had started trading again within the last two weeks after a pause in trading),” These three business sectors included water and waste management, private health and social work activities, and manufacturing, who reported trading at 100%, 99% and 99% respectively.  

The opportunity for growth in cyber security

Sponsored by CybeX Security CybeX is a newly established technology driven global security company, with a focus on the convergence of cyber security and private security services, major event security, counter surveillance, vetting and risk management, critical national infrastructure and debt collection.

The Market

Cyber security has been one of the fastest growing security verticals and markets globally since the turn of the internet age and the global cyber security market is expected to grow from £100bn ($137bn) in 2017 to £200bn ($231bn) by 2022 at a CAGR of 11.0%. The major forces driving this growth in the market are the strict data protective directives and cyber terrorism which has been on the geopolitical spectrum in recent times. In addition, the market is growing rapidly due to the growing security needs associated with the Internet of Things (‘IoT’), Bring Your Own Device (‘BYOD’) trends and the increased deployment of web and cloud-based business and government applications. Download the CybeX Security Investor Presentation As per a Frost & Sullivan report conducted in 2017, the global security market is forecast to continue to grow at just over 5% annually with cyber security growing at 11%. The global cyber security market can be segmented by various industry verticals, out of which the adoption of security solutions is expected to be the highest in aerospace and defence, as the critical data and applications used are vulnerable to advanced cyber threats. It is expected that over the course of the next few years cyber security will continue to be in high demand and be in high demand and be widely adopted by governments and the private sector.

Integrated Security Solutions

CybeX is aiming to become the largest globally integrated security solutions company with a broad portfolio of security services operating across major industry verticals with multiple end user clients in both the private and public sectors. The cyber security startup will help its clients to enhance their ability to respond to cyber-attacks, benchmark their current data protection capabilities to industry standards whilst evaluating their security and incident response policies to ensure there are no major gaps in their systems. The Company’s attack prevention services include both internal and external assessments to systems, application and facilities that include but are not limited to:
  • Cyber risk assessment and analysis;
  • Vulnerability assessment and penetration testing;
  • Physical security measures and assessments;
  • Wireless network security assessments;
  • Breach and data compromise assessments; and
  • Policy and procedure review and design.
Download the CybeX Security Investor Presentation

Potential Exit

Within five years, the Company will also consider the sale of the entire organisation in order to release cash back to the shareholders, through a trade sale or IPO. The firm should have access to a range of security markets globally, generating revenues in excess of £182m and pre-tax profits of £89.2m. With the firm cemented as a leading online and physical security services company, it is expected to have a net asset value of £129.3m and thus the IPO value could be significantly higher when accounting for EV multiples on exit. With significant in-depth research and analysis, the Company estimates current market EV ratios to be 13.36x and after taking into account risk and liquidity discounts, CybeX could achieve a ratio in the region of 9.3x resulting in an IPO valuation of £830 million or £53.40 per share when taking into account the total number of shares expected to be in issue. Download the CybeX Security Investor Presentation